AccuStem Sciences, Inc. Announces Chairman Purchase of Shares
Rhea-AI Summary
AccuStem Sciences (OTCQB: ACUT), a clinical stage diagnostics company focused on cancer patient outcomes, has announced that Board Chairman Gabriele Cerrone has increased his stake in the company. The Chairman purchased 152,802 additional ACUT shares through open market transactions, bringing his total shareholding to 4,872,759 shares.
Positive
- Chairman's increased stake demonstrates insider confidence in company
- Significant share purchase of 152,802 shares by company insider
- Chairman now holds substantial position of 4.87M shares
Negative
- Company still trades on OTCQB market rather than major exchange
News Market Reaction
On the day this news was published, ACUT declined 4.62%, reflecting a moderate negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
LONDON and PHOENIX, April 08, 2025 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with cancer, announced that its Chairman of the Board, Mr. Gabriele Cerrone, has notified the Company that he has recently purchased an additional 152,802 ACUT shares in the open market. This brings his total holding to 4,872,759 shares.
About AccuStem
AccuStem is a clinical stage diagnostics company dedicated to optimizing outcomes and quality of life for all patients with cancer. We plan to drive innovation in healthcare by offering proprietary molecular testing that addresses unmet clinical needs from cancer screening through treatment and monitoring. By interrogating novel disease pathways, such as tumor “stemness”, we believe our tools will help care teams better understand the biology of each patient’s cancer, leading to more informed decision making. For more information, please visit www.accustem.com.
Investor and Media Contact:
Wendy Blosser
Email: investors@accustem.com
FAQ
How many shares did AccuStem Sciences Chairman purchase in April 2025?
What is the total shareholding of ACUT's Chairman after the recent purchase?
When did the Chairman of AccuStem Sciences (ACUT) increase his stake?
What type of company is AccuStem Sciences (ACUT)?
